Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
Clinical trial NCT04445038 · UNKNOWN
Trial details
- NCT number
- NCT04445038
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2021-03-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.